SARS-CoV-2 Spike Antibodies
The SARS-CoV-2 spike protein remains the central target for vaccines, therapeutic antibodies, and serological assays, but ongoing viral evolution has introduced significant mutations—especially within the RBD—that can alter antibody binding and reduce neutralization potency. As circulating variants continue to diverge from the original 2020 spike, reliance on early-generation reagents is no longer sufficient. For research, diagnostics, and vaccine development, updated spike constructs and antibodies that maintain activity across variant lineages—or are specifically tailored to current sequences—are increasingly essential.
Recommended next Filters:
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | 兔 Chimeric |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | Human Monoclonal |
|
|
|
| SARS-CoV-2 Spike S1 抗体 (Trimer) | SARS Coronavirus-2 (SARS-CoV-2) | Cell culture Monoclonal |
|
|
|
| SARS-CoV-2 Spike S1 抗体 | SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Alpha | 兔 Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | Human Monoclonal |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | 小鼠 Chimeric |
|
|
|
| Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) | SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV) | 小鼠 Chimeric |
|
|
- mIHC (Multiplex Immunohistochemistry (mIHC): 已在此应用中经过独立验证)
- ELISA (ELISA: 有验证图片)
- Neut (Neutralization: 有验证图片)
- BLI (Bio-Layer Interferometry: 有验证图片)
- Bind (Binding Studies: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgM, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG2, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgA, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 所列应用)
- LF (Lateral Flow: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2)
- 宿主
- Cell culture
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- Trimer
- ELISA (ELISA: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Alpha
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- SP185
- 标记
- unconjugated
- 抗体亚型
- IgG kappa
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- Fc Silenced, IgG1, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- 小鼠
- 克隆形成能力
- Chimeric
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgM, kappa
- 抗原表位
- AA 318-510, RBD
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- Neut (Neutralization: 所列应用)
- Crys (Crystallization: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
- 宿主
- 小鼠
- 克隆形成能力
- Chimeric
- 克隆
- CR3022
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG2b, kappa
- 抗原表位
- AA 318-510, RBD